SCHEMBL6539461

SCHEMBL6539461

CCN(CC)C(=O)c1nc(-c2ccc(OC)nc2)c(-c2ccc(OCCNS(C)(=O)=O)cc2)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.38
ALDH1A1 P00352 3/20 0.37
PPARD Q03181 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
RCE1 Q9Y256 1/20 0.36
DYRK3 O43781 1/20 0.35
ROCK2 O75116 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35
CDK1 P06493 1/20 0.35
ROS1 P08922 1/20 0.35
PIM1 P11309 1/20 0.35
PRKACA P17612 1/20 0.35
RPS6KB1 P23443 1/20 0.35
CDK2 P24941 1/20 0.35
AKT1 P31749 1/20 0.35
CLK2 P49760 1/20 0.35
GSK3B P49841 1/20 0.35
IRAK1 P51617 1/20 0.35
RPS6KA3 P51812 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6232652 0.88 TAAR1 (0.41) HRH3ALDH1A1PPARDTAAR1RCE1
SCHEMBL6539472 0.87 HRH3 (0.38) HRH3PPARDTAAR1RCE1CDK2
Hydrochloric Acid SCHEMBL6540242 0.85 OXTR (0.40) HRH3ALDH1A1PPARDTAAR1RCE1
SCHEMBL6539374 0.85 PPARD (0.37) ALDH1A1PPARDTAAR1RCE1DYRK3
SCHEMBL6539690 0.83 HPGD (0.42) HRH3ALDH1A1PPARDTAAR1RCE1
SCHEMBL6539662 0.82 PPARD (0.41) PPARDTAAR1RCE1MKNK2OXTR
SCHEMBL6539798 0.81 GSK3B (0.36) ALDH1A1PPARDTAAR1RCE1DYRK3
SCHEMBL6539804 0.81 GSK3B (0.36) ALDH1A1PPARDTAAR1RCE1DYRK3
SCHEMBL6539033 0.81 MEN1 (0.48) ALDH1A1PPARDOXTRMEN1KMT2A
SCHEMBL6539048 0.81 PPARD (0.40) HRH3ALDH1A1PPARDTAAR1RCE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 HRH3 940/4885ALDH1A1 163/4885PPARD 1747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.